Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Media

For media inquiries, please contact:
David Lundy david@corporateeurope.org

As negotiations at the climate talks in Paris move into their second week, the revolving door in Brussels continues to spin energetically, writes Vicky Cann.

Vicky Cann is a campaigner with Corporate Europe Observatory (CEO), a Brussels-based non-governmental organisation, which runs the RevolvingDoorWatch project.

The Brussels ‘revolving door’ has allowed Big Energy to remain close to European climate and energy decision makers ahead of December’s Paris COP21 climate talks, a new report shows.

The report, by transparency campaigning and research group Corporate Europe Observatory (CEO), highlights the easy and frequent flow of EU public servants and elected representatives into corporate jobs linked  to the fossil fuel industry, or those who represent them, and vice versa.

 

CEO turns the spotlight on another of the interest groups operating within the European Parliament.

The voice of the Dutch Government has been loud and clear in Brussels on the issue of cisgenic plants. The Dutch have waged a sustained campaign to have new GM techniques – and in particular cisgenesis – excluded from EU GMO regulations. Several Dutch ministries, the Dutch Parliament, the Dutch Permanent Representation in Brussels, and Dutch MEPs have energetically pursued this goal.

At least one developer of new GM crops – Canadian-based Cibus – has attempted to bypass the European policy process by presenting policy makers with a fait accompli: decisions by individual Member States on the regulatory status of new techniques, as well as prematurely-launched trials of new GM crops.

The biotech industry is staging an audacious bid to have a whole new generation of genetic engineering techniques excluded from European regulations. The pending decision of the European Commission on the regulation of these so-called 'new GMOs' represents a climax point in the ongoing below-the-radar attack by industry on GM laws.

The corporate lobby tour

Stop the Crop

Alternative Trade Mandate